Loading...
Market
Which region will first report a significant decrease in mpox cases after using Abbott's test by June 2025?
2
Resolution / Starting Odds
Africa • 25%
Asia • 25%
Europe • 25%
South America • 25%
Regional health reports or WHO announcements
Story
WHO Approves Abbott's Alinity m MPXV Assay as First Mpox Test for Emergency Use
Oct 4, 2024, 07:46 AM
The World Health Organization has approved the first diagnostic test for mpox, formerly known as monkeypox, under its Emergency Use Listing procedure, marking an important milestone in expanding global access to mpox testing amid rising outbreaks in Africa. The approved test, called the Alinity m MPXV assay, is manufactured by Abbott Molecular, a division of Abbott Laboratories. This emergency use authorization enables countries to detect the virus more quickly and effectively, strengthening their responses to outbreaks.
View original story
Similar markets
Africa • 25%
Americas • 25%
Europe • 25%
Asia • 25%
United Kingdom • 25%
Europe excluding UK • 25%
Africa • 25%
Other • 25%
Africa • 25%
Americas • 25%
Europe • 25%
Asia • 25%
Africa • 25%
Asia • 25%
Americas • 25%
Europe • 25%
Africa • 25%
Americas • 25%
Europe • 25%
Asia • 25%
Africa • 25%
Americas • 25%
Europe • 25%
Asia • 25%
Africa • 25%
Americas • 25%
Europe • 25%
Asia • 25%
Democratic Republic of Congo • 25%
Kenya • 25%
Nigeria • 25%
Burundi • 25%
Democratic Republic of Congo • 25%
Burundi • 25%
Nigeria • 25%
Other • 25%
Africa • 25%
North America • 25%
Europe • 25%
Asia • 25%
Burundi • 25%
Democratic Republic of Congo • 25%
Angola • 25%
Other • 25%
Locally-made PCR tests • 25%
Imported PCR tests • 25%
Rapid antigen tests • 25%
Other methods • 25%